Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

Working Group

doi:10.1016/j.dld.2020.06.045

Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging

Working Group

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Review article › peer-review

Abstract

Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.

Original language	English
Journal	Digestive and Liver Disease
DOIs	https://doi.org/10.1016/j.dld.2020.06.045
Publication status	Published - 2020

Keywords

Distal cholangiocarcinoma
Gene mutations
Histology
Intrahepatic cholangiocarcinoma
Perihilar cholangiocarcinoma
Risk factors
Staging

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1016/j.dld.2020.06.045

Fingerprint Dive into the research topics of 'Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging'. Together they form a unique fingerprint.

Cite this

@article{ee299ff2eba74f07ac47c7a162601652,

title = "Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging",

abstract = "Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.",

keywords = "Distal cholangiocarcinoma, Gene mutations, Histology, Intrahepatic cholangiocarcinoma, Perihilar cholangiocarcinoma, Risk factors, Staging",

author = "{Working Group} and Domenico Alvaro and Cesare Hassan and Vincenzo Cardinale and Guido Carpino and Luca Fabris and Enrico Gringeri and Vincenza Granata and Massimiliano Mutignani and Helen Morement and Felice Giuliante and Alfredo Guglielmi and Lorenzo Ridola and Marco Marzioni and Gianluca Grazi and Maria Guido and Giulio, {Emilio Di} and Giuseppe Tonini and Francesco Pantano and Rosanna Venere and Bragazzi, {Maria Consiglia} and Francesca Biancanello and Jessica Faccioli and Aurora Giannetti and Marcello Cintolo and Giunta, {Michela Di} and Martina Gambato and Alberto Lasagni and Francesco Izzo and Antonio Avallone and Jesus Banales and Massimo Rossi and Carlo Catalano and Andrea Laghi and Giulia D'amati and Mancino, {Maria Grazia}",

year = "2020",

doi = "10.1016/j.dld.2020.06.045",

language = "English",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I

T2 - Classification, diagnosis and staging

AU - Working Group

AU - Alvaro, Domenico

AU - Hassan, Cesare

AU - Cardinale, Vincenzo

AU - Carpino, Guido

AU - Fabris, Luca

AU - Gringeri, Enrico

AU - Granata, Vincenza

AU - Mutignani, Massimiliano

AU - Morement, Helen

AU - Giuliante, Felice

AU - Guglielmi, Alfredo

AU - Ridola, Lorenzo

AU - Marzioni, Marco

AU - Grazi, Gianluca

AU - Guido, Maria

AU - Giulio, Emilio Di

AU - Tonini, Giuseppe

AU - Pantano, Francesco

AU - Venere, Rosanna

AU - Bragazzi, Maria Consiglia

AU - Biancanello, Francesca

AU - Faccioli, Jessica

AU - Giannetti, Aurora

AU - Cintolo, Marcello

AU - Giunta, Michela Di

AU - Gambato, Martina

AU - Lasagni, Alberto

AU - Izzo, Francesco

AU - Avallone, Antonio

AU - Banales, Jesus

AU - Rossi, Massimo

AU - Catalano, Carlo

AU - Laghi, Andrea

AU - D'amati, Giulia

AU - Mancino, Maria Grazia

PY - 2020

Y1 - 2020

N2 - Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.

AB - Cholangiocarcinoma (CCA) is the second most common primary liver cancer, characterized by a poor prognosis and resistance to chemotherapeutics. The progressive increase in CCA incidence and mortality registered worldwide in the last two decades and the need to clarify various aspects of clinical management have prompted the Italian Association for the Study of the Liver (AISF) to commission the drafting of dedicated guidelines in collaboration with a group of Italian scientific societies. These guidelines have been formulated in accordance with the Italian National Institute of Health indications and developed by following the GRADE method and related advancements.

KW - Distal cholangiocarcinoma

KW - Gene mutations

KW - Histology

KW - Intrahepatic cholangiocarcinoma

KW - Perihilar cholangiocarcinoma

KW - Risk factors

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85090489680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090489680&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2020.06.045

DO - 10.1016/j.dld.2020.06.045

M3 - Review article

C2 - 32893173

AN - SCOPUS:85090489680

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

ER -